retatrutide type 2 diabetes phase 2 results 2024 2025 Weight loss with as compared to licenced obesity Phase III retatrutide study demonstrates

This theory doesn't explain why better metabolism causes dysesthesia

These findings make Retatrutide a next-generation weight management peptide , showing even greater potential than current single or dual-agonist medications

If retatrutide is approved in the UK and youre already taking Mounjaro, switching would normally involve stopping Mounjaro, allowing a washout period of one week, and starting retatrutide at an equivalent dose

To characterize the class-level safety profile, K-Dense Web performed a Proportional Reporting Ratio (PRR) disproportionality analysis using the openFDA FAERS API, comparing semaglutide and tirzepatide across six safety signals from 2020 through April 2026